Production (Stage)
BioCryst Pharmaceuticals, Inc.
BCRX
$10.59
$0.201.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.32% | -17.52% | -17.00% | -33.76% | -15.47% |
| Total Receivables | 54.15% | 38.84% | 35.06% | 19.23% | 24.56% |
| Inventory | -76.92% | -71.81% | -74.48% | -83.54% | 8.43% |
| Prepaid Expenses | -22.06% | -29.63% | -18.66% | 16.40% | 21.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -83.82% | -88.36% | -48.67% | 14.04% | 22.90% |
| Total Current Assets | -8.30% | -14.92% | -14.99% | -28.88% | -8.92% |
|
|
|||||
| Total Current Assets | -8.30% | -14.92% | -14.99% | -28.88% | -8.92% |
| Net Property, Plant & Equipment | -5.49% | -5.40% | -3.67% | 29.04% | 34.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37,807.59% | 35,330.00% | 31,636.71% | -- | -- |
| Total Assets | 2.60% | -5.13% | -6.06% | -10.84% | -8.21% |
|
|
|||||
| Total Accounts Payable | -15.63% | -44.27% | 27.59% | -43.94% | 90.44% |
| Total Accrued Expenses | 16.89% | 10.12% | 34.64% | 18.99% | 5.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.24% | 35.23% | 1,472.66% | 1,152.21% | 1,054.64% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.62% | 6.93% | 69.20% | 38.04% | 40.82% |
|
|
|||||
| Total Current Liabilities | 16.62% | 6.93% | 69.20% | 38.04% | 40.82% |
| Long-Term Debt | -3.81% | -1.89% | -4.45% | -1.32% | 8.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.09% | -10.57% | 1.77% | 80.58% | 87.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -1.28% | -0.63% | 2.77% | 3.20% | 12.65% |
|
|
|||||
| Common Stock & APIC | 6.24% | 5.63% | 5.36% | 4.96% | 5.13% |
| Retained Earnings | -3.11% | -5.29% | -7.65% | -9.22% | -13.83% |
| Treasury Stock & Other | 46.82% | -31.11% | 186.63% | -19.28% | 31.79% |
| Total Common Equity | 5.09% | -4.48% | -14.01% | -22.35% | -45.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.09% | -4.48% | -14.01% | -22.35% | -45.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.09% | -4.48% | -14.01% | -22.35% | -45.05% |
|
|
|||||